ZYME · NASDAQ
Zymeworks (ZYME) Stock Price & Fundamentals
Zymeworks (ZYME) closed at $348.53 on Oct 9, 2026, up 1.07% from the previous close of $344.84.
Share price, past year
1Y +1.08%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $348.53 |
| Sep 30, 2026 | $350.54 |
| Aug 31, 2026 | $345.02 |
| Jul 31, 2026 | $347.48 |
| Jun 30, 2026 | $342.62 |
| May 29, 2026 | $334.99 |
| Apr 30, 2026 | $331.72 |
| Mar 31, 2026 | $316.76 |
| Feb 27, 2026 | $318.98 |
| Jan 30, 2026 | $348.18 |
| Dec 31, 2025 | $354.23 |
| Nov 28, 2025 | $357.72 |
| Oct 31, 2025 | $343.28 |
Key statistics
- Market cap
- $24.89B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.44
- Revenue (TTM)
- $37.13M
- Net income (TTM)
- −$149.99M
- Shares outstanding
- 71.4M
- Dividend yield
- —
- 52-week range
- $311.65 – $362.43
Zymeworks's market cap is $24.89B, based on a share price of $348.53 and 71.4M shares outstanding as of Jun 30, 2026.
Financials
Zymeworks reported revenue of $105.97M for fiscal 2025, up 38.87% from fiscal 2024.
Zymeworks reported a net loss of $81.13M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $105.97M | +38.9% | −$81.13M | −76.6% | −$1.08 | −$34.53M |
| FY2024ended Dec 31, 2024 | $76.30M | +0.4% | −$122.70M | −160.8% | −$1.62 | −$112.05M |
| FY2023ended Dec 31, 2023 | $76.01M | −81.6% | −$118.67M | −156.1% | −$1.72 | −$120.80M |
| FY2022ended Dec 31, 2022 | $412.48M | +1,446.0% | $124.34M | 30.1% | $1.90 | $135.96M |
| FY2021ended Dec 31, 2021 | $26.68M | −31.5% | −$211.84M | −794.0% | −$4.61 | −$204.86M |
| FY2020ended Dec 31, 2020 | $38.95M | — | −$180.55M | −463.5% | −$3.58 | −$155.71M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $4.59M | −$45.02M | −$0.62 |
| Q1 FY2026ended Mar 31, 2026 | $2.41M | −$44.16M | −$0.59 |
| Q4 FY2025ended Dec 31, 2025 | $2.52M | −$41.21M | — |
| Q3 FY2025ended Sep 30, 2025 | $27.61M | −$19.60M | −$0.26 |
| Q2 FY2025ended Jun 30, 2025 | $48.73M | $2.32M | $0.03 |
| Q1 FY2025ended Mar 31, 2025 | $27.11M | −$22.64M | −$0.30 |
| Q4 FY2024ended Dec 31, 2024 | $31.03M | −$23.51M | — |
| Q3 FY2024ended Sep 30, 2024 | $16.00M | −$29.85M | −$0.39 |
Company profile
- Name
- Zymeworks Inc.
- Ticker
- ZYME
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 108 Patriot Drive, Suite A, Middletown, DE 19709
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001937653
Recent SEC filings
- Sep 23, 2026
- Aug 25, 2026
- Aug 6, 2026
- Aug 6, 2026
- Jun 29, 2026
- May 14, 2026
- May 7, 2026
- May 7, 2026
Frequently asked questions
What is Zymeworks's stock price?
Zymeworks (ZYME) closed at $348.53 on Oct 9, 2026, up 1.07% from the previous close of $344.84.
What is Zymeworks's market cap?
Zymeworks's market cap is $24.89B, based on a share price of $348.53 and 71.4M shares outstanding as of Jun 30, 2026.
How much revenue does Zymeworks make?
Zymeworks reported revenue of $105.97M for fiscal 2025, up 38.87% from fiscal 2024.
Does Zymeworks pay a dividend?
Zymeworks's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Zymeworks Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures